Keyphrases
Zika Virus
100%
Virus
48%
Chikungunya Virus (CHIKV)
44%
Zika Virus Infection
32%
Viremia
26%
Mouse Model
21%
Vaccine Candidate
20%
Venezuelan Equine Encephalitis Virus
20%
West Nile Virus
20%
Neutralizing Antibodies
18%
Virus Strains
17%
Dengue Virus
16%
Virulence
14%
Flavivirus
14%
Live Attenuated
13%
AG129 Mice
13%
Virus Vaccine
12%
Aedes Mosquito
12%
Nonhuman Primate
12%
Venezuelan Equine Encephalitis
12%
Chikungunya Fever
12%
Cynomolgus Macaque
12%
Arbovirus
11%
Immunogenicity
11%
Sylvatic
10%
Transmission Cycles
10%
Fetal Brain
10%
Alphavirus
10%
Zika Vaccine
10%
Microglia
9%
Insect-specific Virus
9%
Vaccination
9%
Internal Ribosome Entry Site
9%
Titer
8%
ChAdOx1
8%
Vaccine Development
8%
Attenuation
8%
Brazil
8%
Aedes Aegypti
8%
Virus Replication
8%
Flaviviridae
8%
Fever
7%
Congenital Zika Syndrome
7%
Vaccine Strain
7%
COVID-19
7%
Monkey
7%
Aedes Albopictus
7%
Envelope Protein
6%
Mosquito-borne
6%
Recombinant
6%
Immunology and Microbiology
Zika Virus
83%
Chikungunya Virus
39%
Viral Disease
35%
Arbovirus
28%
Dengue Virus
23%
Viremia
22%
Neutralizing Antibody
21%
West Nile Virus
20%
Flavivirus
18%
Venezuelan Equine Encephalitis Virus
18%
Virus Strain
17%
Aedes aegypti
16%
Sylvatic
15%
Macaca fascicularis
15%
Titer
15%
Mouse Model
13%
Virus Vaccine
12%
Immunogenicity
11%
Flaviviridae
11%
Aedes albopictus
10%
Equus
10%
Wild Type
10%
Dengue Fever
10%
Lineages
10%
Zika Virus Vaccine
9%
Alphavirus
9%
Dengue Virus 4
9%
Virus Evolution
9%
Internal Ribosome Entry Site
9%
Viral Load
9%
Glycoprotein
8%
Aedes
8%
interferon
8%
Haplorhini
8%
Capsid
7%
Attenuated Vaccine
7%
Live Vaccine
7%
Serotype
7%
Viral Replication
7%
Molecular Cloning
7%
Viral Vector
6%
Immunology
6%
Antibody Response
6%
Viral Envelope
6%
Replicon
6%
Encephalitis Vaccine
6%
Host Range
6%
Geographic Distribution
6%
Mayaro Virus
6%
Virion
6%
Pharmacology, Toxicology and Pharmaceutical Science
Zika Virus
64%
Chikungunya Virus
26%
Infection
25%
Disease
23%
Zika Fever
23%
Mouse Model
15%
Chikungunya
11%
Zika Virus Vaccine
9%
Neutralizing Antibody
9%
Immunogenicity
8%
Syndrome
8%
Flavivirus
7%
Live Vaccine
6%
Viremia
6%
Microcephaly
6%
Mayaro Virus
6%
SARS Coronavirus
6%
Clinical Trial
6%
Antivirus Agent
5%
Venezuelan Equine Encephalitis Virus
5%
Virus Vaccine
5%
Virus Strain
5%